Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1995 Feb;69(2):684–694. doi: 10.1128/jvi.69.2.684-694.1995

Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system.

S A Stohlman 1, C C Bergmann 1, R C van der Veen 1, D R Hinton 1
PMCID: PMC188629  PMID: 7815531

Abstract

Acute infection of the central nervous system by the neurotropic JHM strain of mouse hepatitis virus (JHMV) induces nucleocapsid protein specific cytotoxic T lymphocytes (CTL) not found in the periphery (S. Stohlman, S. Kyuwa, J. Polo, D. Brady, M. Lai, and C. Bergmann, J. Virol. 67:7050-7059, 1993). Peripheral induction of CTL specific for the nucleocapsid protein of JHMV by vaccination with recombinant vaccinia viruses was unable to provide significant protection to a subsequent lethal virus challenge. By contrast, the transfer of nucleoprotein-specific CTL protected mice from a subsequent lethal challenge by reducing virus replication within the central nervous system, demonstrating the importance of the CTL response to this epitope in JHMV infection. Transfer of these CTL directly into the central nervous system was at least 10-fold more effective than peripheral transfer. Histological analysis indicated that the CTL reduced virus replication in ependymal cells, astrocytes, and microglia. Although the CTL were relatively ineffective at reducing virus replication in oligodendroglia, survivors showed minimal evidence of virus persistence within the central nervous system and no evidence of chronic ongoing demyelination.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altintas A., Cai Z., Pease L. R., Rodriguez M. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus. J Immunol. 1993 Sep 1;151(5):2803–2812. [PubMed] [Google Scholar]
  2. Ando K., Guidotti L. G., Cerny A., Ishikawa T., Chisari F. V. CTL access to tissue antigen is restricted in vivo. J Immunol. 1994 Jul 15;153(2):482–488. [PubMed] [Google Scholar]
  3. Baron J. L., Madri J. A., Ruddle N. H., Hashim G., Janeway C. A., Jr Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993 Jan 1;177(1):57–68. doi: 10.1084/jem.177.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bergmann C. C., Tong L., Cua R. V., Sensintaffar J. L., Stohlman S. A. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction. J Immunol. 1994 Jun 15;152(12):5603–5612. [PubMed] [Google Scholar]
  5. Bergmann C. C., Tong L., Cua R., Sensintaffar J., Stohlman S. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J Virol. 1994 Aug;68(8):5306–5310. doi: 10.1128/jvi.68.8.5306-5310.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bergmann C., McMillan M., Stohlman S. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein. J Virol. 1993 Dec;67(12):7041–7049. doi: 10.1128/jvi.67.12.7041-7049.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bergsteindottir K., Brennan A., Jessen K. R., Mirsky R. In the presence of dexamethasone, gamma interferon induces rat oligodendrocytes to express major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9054–9058. doi: 10.1073/pnas.89.19.9054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brinckmann U. G., Bankamp B., Reich A., ter Meulen V., Liebert U. G. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis. J Gen Virol. 1991 Oct;72(Pt 10):2491–2500. doi: 10.1099/0022-1317-72-10-2491. [DOI] [PubMed] [Google Scholar]
  9. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984 Jan 30;132(2):261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Compton S. R., Barthold S. W., Smith A. L. The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci. 1993 Feb;43(1):15–28. [PubMed] [Google Scholar]
  11. Dyken P. R. Subacute sclerosing panencephalitis. Current status. Neurol Clin. 1985 Feb;3(1):179–196. [PubMed] [Google Scholar]
  12. Dörries R., Schwender S., Imrich H., Harms H. Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis. Immunology. 1991 Nov;74(3):539–545. [PMC free article] [PubMed] [Google Scholar]
  13. Erlich S. S., Fleming J. O., Stohlman S. A., Weiner L. P. Experimental neuropathology of chronic demyelination induced by a JHM virus variant (DS). Arch Neurol. 1987 Aug;44(8):839–842. doi: 10.1001/archneur.1987.00520200043016. [DOI] [PubMed] [Google Scholar]
  14. Erlich S. S., Matsushima G. K., Stohlman S. A. Studies on the mechanism of protection from acute viral encephalomyelitis by delayed-type hypersensitivity inducer T cell clones. J Neurol Sci. 1989 Apr;90(2):203–216. doi: 10.1016/0022-510X(89)90102-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fazakerley J. K., Buchmeier M. J. Pathogenesis of virus-induced demyelination. Adv Virus Res. 1993;42:249–324. doi: 10.1016/S0065-3527(08)60087-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fleming J. O., Shubin R. A., Sussman M. A., Casteel N., Stohlman S. A. Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology. 1989 Jan;168(1):162–167. doi: 10.1016/0042-6822(89)90415-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Flory E., Pfleiderer M., Stühler A., Wege H. Induction of protective immunity against coronavirus-induced encephalomyelitis: evidence for an important role of CD8+ T cells in vivo. Eur J Immunol. 1993 Aug;23(8):1757–1761. doi: 10.1002/eji.1830230804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hany M., Oehen S., Schulz M., Hengartner H., Mackett M., Bishop D. H., Overton H., Zinkernagel R. M. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur J Immunol. 1989 Mar;19(3):417–424. doi: 10.1002/eji.1830190302. [DOI] [PubMed] [Google Scholar]
  19. Joly E., Mucke L., Oldstone M. B. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 1991 Sep 13;253(5025):1283–1285. doi: 10.1126/science.1891717. [DOI] [PubMed] [Google Scholar]
  20. KERSTING G., PETTE E. Zur Pathohistologie und Pathogenese der experimentellen JHM-Virusencephalomyelitis des Affen. Dtsch Z Nervenheilkd. 1956;174(3):283–304. [PubMed] [Google Scholar]
  21. Kim K. S., Wass C. A., Cross A. S., Opal S. M. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 1992 Dec;11(6):293–298. [PubMed] [Google Scholar]
  22. Kyuwa S., Cohen M., Nelson G., Tahara S. M., Stohlman S. A. Modulation of cellular macromolecular synthesis by coronavirus: implication for pathogenesis. J Virol. 1994 Oct;68(10):6815–6819. doi: 10.1128/jvi.68.10.6815-6819.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Körner H., Schliephake A., Winter J., Zimprich F., Lassmann H., Sedgwick J., Siddell S., Wege H. Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J Immunol. 1991 Oct 1;147(7):2317–2323. [PubMed] [Google Scholar]
  24. Kündig T. M., Hengartner H., Zinkernagel R. M. T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J Immunol. 1993 Mar 15;150(6):2316–2321. [PubMed] [Google Scholar]
  25. Lampert P. W., Sims J. K., Kniazeff A. J. Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol. 1973 Mar 30;24(1):76–85. doi: 10.1007/BF00691421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lecomte J., Cainelli-Gebara V., Mercier G., Mansour S., Talbot P. J., Lussier G., Oth D. Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Brief report. Arch Virol. 1987;97(1-2):123–130. doi: 10.1007/BF01310740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. May M. J., Ager A. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta. Eur J Immunol. 1992 Jan;22(1):219–226. doi: 10.1002/eji.1830220132. [DOI] [PubMed] [Google Scholar]
  28. Murray R. S., Brown B., Brian D., Cabirac G. F. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol. 1992 May;31(5):525–533. doi: 10.1002/ana.410310511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Murray R. S., Cai G. Y., Hoel K., Zhang J. Y., Soike K. F., Cabirac G. F. Coronavirus infects and causes demyelination in primate central nervous system. Virology. 1992 May;188(1):274–284. doi: 10.1016/0042-6822(92)90757-G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nakanaga K., Yamanouchi K., Fujiwara K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol. 1986 Jul;59(1):168–171. doi: 10.1128/jvi.59.1.168-171.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Oldstone M. B., Blount P., Southern P. J., Lampert P. W. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature. 1986 May 15;321(6067):239–243. doi: 10.1038/321239a0. [DOI] [PubMed] [Google Scholar]
  32. Perlman S., Ries D. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Pathog. 1987 Oct;3(4):309–314. doi: 10.1016/0882-4010(87)90064-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rodriguez M., Pierce M. L., Howie E. A. Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. J Immunol. 1987 May 15;138(10):3438–3442. [PubMed] [Google Scholar]
  34. Shirai M., Pendleton C. D., Ahlers J., Takeshita T., Newman M., Berzofsky J. A. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol. 1994 Jan 15;152(2):549–556. [PubMed] [Google Scholar]
  35. Shubin R. A., Sussman M. A., Fleming J. O., Stohlman S. A. Relapsing encephalomyelitis following transfer of partial immunity to JHM virus. Microb Pathog. 1990 May;8(5):305–314. doi: 10.1016/0882-4010(90)90089-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Smith A. L., Barthold S. W., de Souza M. S., Bottomly K. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch Virol. 1991;121(1-4):89–100. doi: 10.1007/BF01316746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Sorensen O., Saravani A., Dales S. In vivo and in vitro models of demyelinating disease. XVII. The infectious process in athymic rats inoculated with JHM virus. Microb Pathog. 1987 Feb;2(2):79–90. doi: 10.1016/0882-4010(87)90100-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Stewart J. N., Mounir S., Talbot P. J. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology. 1992 Nov;191(1):502–505. doi: 10.1016/0042-6822(92)90220-J. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Stitz L., Schmitz C., Binder D., Zinkernagel R., Paoletti E., Becht H. Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. J Gen Virol. 1990 May;71(Pt 5):1169–1179. doi: 10.1099/0022-1317-71-5-1169. [DOI] [PubMed] [Google Scholar]
  40. Stohlman S. A., Bergmann C., Cua D., Wege H., van der Veen R. Location of antibody epitopes within the mouse hepatitis virus nucleocapsid protein. Virology. 1994 Jul;202(1):146–153. doi: 10.1006/viro.1994.1330. [DOI] [PubMed] [Google Scholar]
  41. Stohlman S. A., Brayton P. R., Fleming J. O., Weiner L. P., Lai M. M. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol. 1982 Dec;63(2):265–275. doi: 10.1099/0022-1317-63-2-265. [DOI] [PubMed] [Google Scholar]
  42. Stohlman S. A., Brayton P. R., Harmon R. C., Stevenson D., Ganges R. G., Matsushima G. K. Natural killer cell activity during mouse hepatitis virus infection: response in the absence of interferon. Int J Cancer. 1983 Mar 15;31(3):309–314. doi: 10.1002/ijc.2910310310. [DOI] [PubMed] [Google Scholar]
  43. Stohlman S. A., Kyuwa S., Cohen M., Bergmann C., Polo J. M., Yeh J., Anthony R., Keck J. G. Mouse hepatitis virus nucleocapsid protein-specific cytotoxic T lymphocytes are Ld restricted and specific for the carboxy terminus. Virology. 1992 Jul;189(1):217–224. doi: 10.1016/0042-6822(92)90697-N. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Stohlman S. A., Kyuwa S., Polo J. M., Brady D., Lai M. M., Bergmann C. C. Characterization of mouse hepatitis virus-specific cytotoxic T cells derived from the central nervous system of mice infected with the JHM strain. J Virol. 1993 Dec;67(12):7050–7059. doi: 10.1128/jvi.67.12.7050-7059.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stohlman S. A., Matsushima G. K., Casteel N., Weiner L. P. In vivo effects of coronavirus-specific T cell clones: DTH inducer cells prevent a lethal infection but do not inhibit virus replication. J Immunol. 1986 Apr 15;136(8):3052–3056. [PubMed] [Google Scholar]
  46. Stohlman S. A., Weiner L. P. Chronic central nervous system demyelination in mice after JHM virus infection. Neurology. 1981 Jan;31(1):38–44. doi: 10.1212/wnl.31.1.38. [DOI] [PubMed] [Google Scholar]
  47. Sussman M. A., Shubin R. A., Kyuwa S., Stohlman S. A. T-cell-mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol. 1989 Jul;63(7):3051–3056. doi: 10.1128/jvi.63.7.3051-3056.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Vennema H., de Groot R. J., Harbour D. A., Horzinek M. C., Spaan W. J. Primary structure of the membrane and nucleocapsid protein genes of feline infectious peritonitis virus and immunogenicity of recombinant vaccinia viruses in kittens. Virology. 1991 Mar;181(1):327–335. doi: 10.1016/0042-6822(91)90499-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wang F. I., Stohlman S. A., Fleming J. O. Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol. 1990 Nov;30(1):31–41. doi: 10.1016/0165-5728(90)90050-W. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wege H., Schliephake A., Körner H., Flory E., Wege H. An immunodominant CD4+ T cell site on the nucleocapsid protein of murine coronavirus contributes to protection against encephalomyelitis. J Gen Virol. 1993 Jul;74(Pt 7):1287–1294. doi: 10.1099/0022-1317-74-7-1287. [DOI] [PubMed] [Google Scholar]
  51. Weiner L. P. Pathogenesis of demyelination induced by a mouse hepatitis. Arch Neurol. 1973 May;28(5):298–303. doi: 10.1001/archneur.1973.00490230034003. [DOI] [PubMed] [Google Scholar]
  52. Wesseling J. G., Godeke G. J., Schijns V. E., Prevec L., Graham F. L., Horzinek M. C., Rottier P. J. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. J Gen Virol. 1993 Oct;74(Pt 10):2061–2069. doi: 10.1099/0022-1317-74-10-2061. [DOI] [PubMed] [Google Scholar]
  53. Williamson J. S., Stohlman S. A. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol. 1990 Sep;64(9):4589–4592. doi: 10.1128/jvi.64.9.4589-4592.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Williamson J. S., Sykes K. C., Stohlman S. A. Characterization of brain-infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J Neuroimmunol. 1991 Jun;32(3):199–207. doi: 10.1016/0165-5728(91)90189-E. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wong G. H., Bartlett P. F., Clark-Lewis I., Battye F., Schrader J. W. Inducible expression of H-2 and Ia antigens on brain cells. Nature. 1984 Aug 23;310(5979):688–691. doi: 10.1038/310688a0. [DOI] [PubMed] [Google Scholar]
  56. Wraith D. C., Vessey A. E., Askonas B. A. Purified influenza virus nucleoprotein protects mice from lethal infection. J Gen Virol. 1987 Feb;68(Pt 2):433–440. doi: 10.1099/0022-1317-68-2-433. [DOI] [PubMed] [Google Scholar]
  57. Yamaguchi K., Goto N., Kyuwa S., Hayami M., Toyoda Y. Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus-specific T cell clones. J Neuroimmunol. 1991 Apr;32(1):1–9. doi: 10.1016/0165-5728(91)90065-F. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Zimprich F., Winter J., Wege H., Lassmann H. Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response. Neuropathol Appl Neurobiol. 1991 Dec;17(6):469–484. doi: 10.1111/j.1365-2990.1991.tb00750.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES